These dose-dependent effects include reductions in: inflammatory pathway activations proinflammatory cytokine and collagen degradation enzyme expressions mitochondrial dysfunction oxidative stress According to the above review, all three studies highlighted that GLP-1 analogs may work to treat RA by inhibiting the nuclear factor kappa-light-chain-enhancer of activated B cells pathway, which can improve immune responses
sometimes increases in HDL Liver : Improvements in fatty liver disease (reduced liver fat, improved liver enzymes) Cardiovascular Improvements : Blood Pressure : Significant reductions in systolic and diastolic blood pressure Cardiovascular Events : According to SELECT trial (semaglutide), 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) Heart Function : Improvements in cardiac structure and function markers Physical Function Improvements : Mobility : Improved ability to walk, climb stairs, engage in physical activities Joint Pain : Reduced knee, hip, and back pain from decreased weight-bearing stress Sleep : Improvements in sleep quality
Uh, and also, you know, eating these-these compounds from plants these are phytochemicals
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist Text PDF Abstract Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist under development for the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis
While this study offers valuable insights, it also underscores the need for further research to explore additional outcomes beyond weight loss
"The LMN must provide the diagnosis being treated, the therapy or product recommended by the provider, the length of time that the patient is being treated, and the provider's signature," explains Sneineh
